These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36160162)

  • 1.
    Seliger B; Al-Samadi A; Yang B; Salo T; Wickenhauser C
    Front Med (Lausanne); 2022; 9():971726. PubMed ID: 36160162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy.
    Driehuis E; Kolders S; Spelier S; Lõhmussaar K; Willems SM; Devriese LA; de Bree R; de Ruiter EJ; Korving J; Begthel H; van Es JH; Geurts V; He GW; van Jaarsveld RH; Oka R; Muraro MJ; Vivié J; Zandvliet MMJM; Hendrickx APA; Iakobachvili N; Sridevi P; Kranenburg O; van Boxtel R; Kops GJPL; Tuveson DA; Peters PJ; van Oudenaarden A; Clevers H
    Cancer Discov; 2019 Jul; 9(7):852-871. PubMed ID: 31053628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck cancer organoids as a promising tool for personalized cancer therapy: A literature review.
    Mohtasham N; Mohajer Tehran F; Abbaszadeh H
    Health Sci Rep; 2022 Apr; 5(3):e580. PubMed ID: 35387311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine.
    Gilazieva Z; Ponomarev A; Rutland C; Rizvanov A; Solovyeva V
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
    Kochanek SJ; Close DA; Johnston PA
    Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Multi-Dimensional Cellular Models as Emerging Reality to Reproduce
    Bassi G; Grimaudo MA; Panseri S; Montesi M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines.
    Close DA; Johnston PA
    SLAS Discov; 2022 Jan; 27(1):39-54. PubMed ID: 35058175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional in vitro culture models in oncology research.
    Jubelin C; Muñoz-Garcia J; Griscom L; Cochonneau D; Ollivier E; Heymann MF; Vallette FM; Oliver L; Heymann D
    Cell Biosci; 2022 Sep; 12(1):155. PubMed ID: 36089610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.
    Pinto B; Henriques AC; Silva PMA; Bousbaa H
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
    Ferreira LP; Gaspar VM; Mano JF
    Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preclinical models in head and neck tumors : Evaluation of cellular and molecular resistance mechanisms in the tumor microenvironment].
    Affolter A; Hess J
    HNO; 2016 Dec; 64(12):860-869. PubMed ID: 27837212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors.
    April-Monn SL; Wiedmer T; Skowronska M; Maire R; Schiavo Lena M; Trippel M; Di Domenico A; Muffatti F; Andreasi V; Capurso G; Doglioni C; Kim-Fuchs C; Gloor B; Zatelli MC; Partelli S; Falconi M; Perren A; Marinoni I
    Neuroendocrinology; 2021; 111(3):273-287. PubMed ID: 32241015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer.
    Shan F; Close DA; Camarco DP; Johnston PA
    Assay Drug Dev Technol; 2018 Jan; 16(1):27-50. PubMed ID: 29215913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the use of 3D colorectal cancer models for novel drug discovery.
    Baião A; Dias S; Soares AF; Pereira CL; Oliveira C; Sarmento B
    Expert Opin Drug Discov; 2022 Jun; 17(6):569-580. PubMed ID: 35343351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.
    Miserocchi G; Spadazzi C; Calpona S; De Rosa F; Usai A; De Vita A; Liverani C; Cocchi C; Vanni S; Calabrese C; Bassi M; De Luca G; Meccariello G; Ibrahim T; Schiavone M; Mercatali L
    J Pers Med; 2022 May; 12(6):. PubMed ID: 35743639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel design of microfluidic platform for metronomic combinatorial chemotherapy drug screening based on 3D tumor spheroid model.
    Sankar S; Mehta V; Ravi S; Sharma CS; Rath SN
    Biomed Microdevices; 2021 Oct; 23(4):50. PubMed ID: 34596764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
    Struzyna LA; Watt ML
    Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.